This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Endocrine Surgery  • Surgical Oncology  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Brown et al¹ in a recent issue of the ARCHIVES is an excellent series of patients undergoing pancreaticoduodenectomy for ampullary cancer from an institution that has had substantial experience in performing the Whipple procedure. There was only 1 in-hospital postoperative death for an admirably low mortality of 2%. The pancreatic cutaneous fistula rate of 29% and the overall morbidity rate of 47% were high, but in these patients with normal textured glands and a small, normal pancreatic duct, theses figures are in line with other recent series.

What is different in this series is that the 5-year survival rate was 78% in patients with node-negative disease. In addition, they had no tumor deaths after 3 years. These figures are definitely superior to other studies published in the last 10 years. Why are the results in this series superior? First, it is a small series that had . . . [Full Text of this Article]

AUTHOR INFORMATION
John L. Cameron, MD